Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19

• A clinical worsening in CIDP may occur in concomitance with COVID-19. • Cytokine hyperactivation triggered by SARS-CoV-2 infection might be a possible mechanism. • The management of these patients is particularly challenging.

Detalles Bibliográficos
Autores principales: Abu-Rumeileh, Samir, Garibashvili, Tamara, Ruf, Wolfgang, Fangerau, Tanja, Kassubek, Jan, Althaus, Katharina, Otto, Markus, Senel, Makbule
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Response to letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462872/
https://www.ncbi.nlm.nih.gov/pubmed/32911389
http://dx.doi.org/10.1016/j.jns.2020.117106
_version_ 1783577010527797248
author Abu-Rumeileh, Samir
Garibashvili, Tamara
Ruf, Wolfgang
Fangerau, Tanja
Kassubek, Jan
Althaus, Katharina
Otto, Markus
Senel, Makbule
author_facet Abu-Rumeileh, Samir
Garibashvili, Tamara
Ruf, Wolfgang
Fangerau, Tanja
Kassubek, Jan
Althaus, Katharina
Otto, Markus
Senel, Makbule
author_sort Abu-Rumeileh, Samir
collection PubMed
description • A clinical worsening in CIDP may occur in concomitance with COVID-19. • Cytokine hyperactivation triggered by SARS-CoV-2 infection might be a possible mechanism. • The management of these patients is particularly challenging.
format Online
Article
Text
id pubmed-7462872
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-74628722020-09-02 Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19 Abu-Rumeileh, Samir Garibashvili, Tamara Ruf, Wolfgang Fangerau, Tanja Kassubek, Jan Althaus, Katharina Otto, Markus Senel, Makbule J Neurol Sci Response to letter to the Editor • A clinical worsening in CIDP may occur in concomitance with COVID-19. • Cytokine hyperactivation triggered by SARS-CoV-2 infection might be a possible mechanism. • The management of these patients is particularly challenging. Elsevier B.V. 2020-11-15 2020-09-02 /pmc/articles/PMC7462872/ /pubmed/32911389 http://dx.doi.org/10.1016/j.jns.2020.117106 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Response to letter to the Editor
Abu-Rumeileh, Samir
Garibashvili, Tamara
Ruf, Wolfgang
Fangerau, Tanja
Kassubek, Jan
Althaus, Katharina
Otto, Markus
Senel, Makbule
Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19
title Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19
title_full Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19
title_fullStr Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19
title_full_unstemmed Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19
title_short Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19
title_sort exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with covid-19
topic Response to letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462872/
https://www.ncbi.nlm.nih.gov/pubmed/32911389
http://dx.doi.org/10.1016/j.jns.2020.117106
work_keys_str_mv AT aburumeilehsamir exacerbationofchronicinflammatorydemyelinatingpolyneuropathyinconcomitancewithcovid19
AT garibashvilitamara exacerbationofchronicinflammatorydemyelinatingpolyneuropathyinconcomitancewithcovid19
AT rufwolfgang exacerbationofchronicinflammatorydemyelinatingpolyneuropathyinconcomitancewithcovid19
AT fangerautanja exacerbationofchronicinflammatorydemyelinatingpolyneuropathyinconcomitancewithcovid19
AT kassubekjan exacerbationofchronicinflammatorydemyelinatingpolyneuropathyinconcomitancewithcovid19
AT althauskatharina exacerbationofchronicinflammatorydemyelinatingpolyneuropathyinconcomitancewithcovid19
AT ottomarkus exacerbationofchronicinflammatorydemyelinatingpolyneuropathyinconcomitancewithcovid19
AT senelmakbule exacerbationofchronicinflammatorydemyelinatingpolyneuropathyinconcomitancewithcovid19

Ejemplares similares